Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NAD+ synthesis pathway encompasses the biochemical reactions responsible for producing nicotinamide adenine dinucleotide (NAD+), a crucial coenzyme involved in redox reactions, energy metabolism, and cellular signaling. NAD+ is synthesized via the de novo pathway from tryptophan and through salvage pathways that recycle nicotinamide, nicotinic acid, or nicotinamide riboside. Key enzymes include QPRT, NAMPT, NAPRT, NRK1/2, NMNATs, and NADS. NAD+ serves as a substrate for sirtuins, PARPs, and CD38/157 ectoenzymes, playing a vital role in various biological processes. Dysregulation of NAD+ levels is implicated in aging and disease, making it a potential therapeutic target.
Modulation of NAD+ levels through inhibition or activation of key enzymes in the de novo or salvage pathways. Indirectly affects downstream targets like sirtuins and PARPs.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAD+ Synthesis Pathway.